Septomics (Centre for Innovation Competence) is a legally dependent scientific institution of the Friedrich-Schiller-University Jena. Additionally, Septomics is scientifically and administratively linked to the Jena University Hospital and the Leibniz-Institute for Natural Product Research and Infection Biology – Hans-Knoell-Institute (HKI). All supporting institutions signed a cooperation contract and agreed to support Septomics and to cooperate in the field of molecular-biological fundamental and clinical translational research. The administration of the University and University Hospital supports Septomics through financial and personnel management, procurement and facility management.
The two research groups Fungal Septomics and Host Septomics as well as the clinical research group Clinical Septomics are the “engine” of Septomics. The research groups are coordinated by their particular group's leader. The clinical research group is funded by the State of Thuringia and managed by the holder of the Endowed Paul Martini Professorship for “Clinical Sepsis Research”. The group leaders enjoy freedom concerning their research within a strategically specified frame. They determine the realization of the research strategy and the content of the different research projects. Group leaders decide personnel recruitment and are responsible for the individual progress of all group members. The group leaders have BMBF (Federal Ministry of Education and Research) funding for investments and consumables as well as external funding at their own disposal.